Barclays Maintains Overweight on JBS, Lowers Price Target to $20

Benzinga Newsdesk www.benzinga.com Negative 81.2%

Neg 81.2% Neu 0% Pos 0%

Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $21 to $20.